Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium channel on pancreatic beta cell membranes is a hetero-octameric ion channel composed primarily of four pore-forming inwardly rectifying potassium subunits (Kir6.2, encoded by KCNJ11) and four regulatory sulfonylurea receptor subunits (SUR1, encoded by ABCC8). This structure allows it to sense changes in cellular metabolism via intracellular nucleotides—primarily ATP and MgADP—which regulate its open/closed state. When blood glucose rises, increased ATP closes these channels via binding at Kir6.2; this leads to membrane depolarization, opening voltage-dependent calcium channels, influx of Ca²⁺ ions into the cell, and subsequent exocytosis/release of insulin granules from the pancreatic beta cell. Conversely, when ADP/MgADP predominates during low metabolic activity/glucose levels or under pharmacologic influence by diazoxide-type drugs acting on SUR1 domains—the channels remain open—hyperpolarizing the membrane and inhibiting insulin release.[1][2][3] Dysfunctional regulation through genetic mutation or drug interaction underlies several diseases including congenital hyperinsulinism/hypoglycemia syndromes as well as certain monogenic forms/types/subtypes/variants/forms/presentations/manifestations/expression/profiles/spectra/families/classes/groups/categories/kinds/types/forms/subtypes/presentations/profiles/spectra/families/classes/groups/categories/kinds/types/forms/subtypes/presentations/profiles/spectra/families/classes/groups/categories/kinds/types/forms/subtypes/presentations/profiles/spectra/families/classes/groups/categories/kinds/types/forms/subtypes/presentations/profiles/spectra/families/classes/groups/categories/kinds/types/forms/subtypes/presentations/profiles/spectra/families/classes/groups/categories/kinds/types/forms/subtypes presentations profiles spectra families classes groups categories kinds types forms subtypes presentations profiles spectra families classes groups categories kinds types forms subtypes presentations profiles spectra families classes groups categories kinds types forms subtypes presentations profiles spectra families classes groups categories kinds types forms subtypes presentations profiles spectra families classes groups categories kinds types forms subtypes presentations profiles spectra families classes groups categories kinds types forms subtypes presentations profiles spectra families classes groups categories kinds types forms subtypes presentations profiles spectra families classes groups categories kinds types forms subtypes presentations profiles spectra families classes groups categories kinds types forms subtypessubgroupssubclassesofdiabetesmellitus.[4]
Drugs targeting this molecule act by: - Sulfonylureas/meglitinides: Bind to the SUR1 subunit and close the KATP channels, leading to depolarization, opening of voltage-gated calcium channels, increased intracellular calcium, and stimulation of insulin release from pancreatic beta cells[2]. - Diazoxide: Binds SUR1 and keeps the KATP channels open longer; prevents depolarization and suppresses inappropriate insulin release.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive potassium channel (pancreatic beta-cell type) (KATP channel (beta-cell type) or Kir6.2/SUR1 complex).